Get in touch Contact us
Search Spire
Please type into the search bar above to begin your search
Please type three or more characters above to begin your search
Dr Chit Cheng Yeoh
Dr Chit Cheng Yeoh

Dr Chit Cheng Yeoh

Consultant Medical Oncologist

MBBS, MD, BMedSc., MRCP (London), PhD

Make an enquiry

I am a Consultant Medical Oncologist specialising in acute oncology, melanoma, ovarian cancer and cancer of unknown primary.

I see patients who require specialist cancer care, with either two or more organs involved, which require urgent diagnostic investigation and treatment. I can potentially begin chemotherapy treatment within five days of referral.

I completed my specialist training at University College London and have practiced as a specialist consultant since September 2012. I continuously keep updated with news from different oncology subspecialties as well as interdepartmental subspecialties.

Awards: 2018 Awarded Prof Alexander Spiers Keynote Lecture Medal, Royal College Physicians Edinburgh; 2016 QiC Award and Clinical Excellence Award holder; 2014 Best Cancer Team Awarded by Quality in Care (QiC); 2013 Best Innovation Team, Westminster, Acute Oncology Walk-in Bay.

I am a part of Barts and the London Hospital/Queen Mary Alumni group.

Read more...

Treatment information

Some of the principal treatments carried out by Dr Chit Cheng Yeoh at Spire include:

Oncology

Other treatments

  • Psychosocial mental health
  • Dietitian and nutrition health

Get in touch

61567
True
consultant
Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

We will use your personal information to process your enquiry. For further information, please see our privacy policy.


Additional information

Chemotherapy
Gynaecological cancer
Haemotological oncology
Immunology
Oncology
Pain relief
Reproductive health
Skin cancer

Special clinical interests: Immunotherapy; Early Diagnosis and Treatment; Direct Access to Walk-in Oncology Clinic; One stop Oncology Investigations; Personalised Molecular Typing of Cancer; CARIS gene Chip; Ion Torrents 31-targetable gene; Mammaprint Chip or Oncotype DX Chip; Genetic Counselling; BRCA 1 and BCRA 2 mutation; Lynch Syndrome; Li Fraumeni Syndrome; Dietetic Counselling: Gerson diet.

MB BS, B Med Sc / University of Ireland (Cork) / 1997
Bachelor of Medicine and Surgery, Bachelor of Medical Science as an intercalated degree

PhD / Queen Mary University, London / 2012
Molecular Biology

Professional memberships

Medical Defence Union

The European Society for Medical Oncology

Association of Cancer Physician

American Society of Clinical Oncology

The Royal College of Physicians

Professional leadership

Lead Clinician in Acute Oncology
Advisory to Health Boards on Acute Oncology Set up
Chief Investigator of Mindfulness Trial for Ovarian Cancer (MoVA) (2016)
Principle PhD Supervisor for Molecular Oncology PhD student for University of Portsmouth (UoP) (2016)
Laboratory Supervisor in QA Hospital
Principle Investigator (P.I) & Co-Inv to many Oncology trials
CMT Trainee in Hampshire rotation (2014-2016)

  • Malignant Melanoma, commonest cancer as first presentation via Acute Oncology's Cancer Unknown Primary Pathway, Comprehensive Audit 2015. Oral Presentation in Post-ASCO Skin Cancer Meetings in Munich, June 2015.
  • Genomic expression of malignant ovarian ascites fluid (MTOC trial) collected from 66 ovarian cancer patient, primary ascites fluid. Poster publication, Seville 2015, Feb.

Articles

Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer

Media Coverage

Acute Oncology: Chit Cheng Yeoh

Consultant Medical Oncologist, Queen Alexandra Hospital, Portsmouth.

Chair of Acute Oncology Steering Meetings.

I'm versatile in many Chinese Dialects including Mandarin, Cantonese, Hokkien, and Hainan.

I am fluent in English, Malay, Indonesian and beginner Dutch.

Private secretary Mary Clark
Private secretary telephone 02392 286000 ext 4784
Private secretary email mary.clark6@nhs.net